EDGAR Filing Documents for 0001157523-13-001624

Form 8-K - Current report:

SEC Accession No. 0001157523-13-001624

Filing Date

2013-04-01

Accepted

2013-04-01 09:18:21

Documents

Period of Report

2013-03-29

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	OPEXA THERAPEUTICS, INC. 8-K	a50600443.htm	8-K	38710
2	EXHIBIT 10.1	a50600443ex10_1.htm	EX-10.1	122217
3	EXHIBIT 10.2	a50600443ex10_2.htm	EX-10.2	44295
4	EXHIBIT 10.3	a50600443ex10_3.htm	EX-10.3	34453
5	EXHIBIT 99.1	a50600443ex99_1.htm	EX-99.1	23302
	Complete submission text file	0001157523-13-001624.txt		264529

Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381

Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331

Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)